Finasteride (CAS 98319-26-7) api-finasteride

Finasteride (CAS 98319-26-7) is a high-purity 5α-reductase inhibitor API with a specific molecular target, effectively blocking the conversion of testosterone to dihydrotestosterone (DHT). Its refined crystalline powder form ensures consistent potency and low impurity levels, making it a reliable active ingredient for pharmaceutical formulations. As a clinically proven agent, it addresses two key indications: benign prostatic hyperplasia (BPH) and male androgenetic alopecia.

Tailored for pharmaceutical manufacturers and medical research institutions, this product adheres to strict international quality standards. It meets the critical demand for safe, targeted treatments—alleviating BPH symptoms by reducing prostate size and slowing male pattern hair loss by inhibiting DHT-induced follicle miniaturization. Its stable chemical structure guarantees a long shelf life, supporting flexible formulation development for oral medications that ensure patient compliance and clinical efficacy.